These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1404961)

  • 1. [Clinical assessment of urinary free L-fucose levels].
    Araki E; Kamiya K; Kawauchi A; Koike T; Takatsuka J; Takeuchi S; Namba M; Shida S; Ishiguro T; Tomoyoshi T
    Rinsho Byori; 1992 Aug; 40(8):868-74. PubMed ID: 1404961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary level of L-fucose as a marker of alcoholic liver disease.
    Yamauchi M; Kimura K; Maezawa Y; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Toda G
    Alcohol Clin Exp Res; 1993 Apr; 17(2):268-71. PubMed ID: 8488966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, simple enzymatic assay of free L-fucose in serum and urine, and its use as a marker for cancer, cirrhosis, and gastric ulcers.
    Sakai T; Yamamoto K; Yokota H; Hakozaki-Usui K; Hino F; Kato I
    Clin Chem; 1990 Mar; 36(3):474-6. PubMed ID: 2311216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymic determination of urinary free L-fucose.
    Endo M; Matsue H; Sato S; Majima M; Hiyama N
    Clin Chim Acta; 1980 May; 103(3):269-75. PubMed ID: 7398072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination assay of urinary free L-fucose and trypsin inhibitor may be useful indicators of disease activity in patients with hematologic malignancies.
    Takubo T; Aoyama Y; Nakamae H; Tanaka K; Ohta K; Yamane T; Hino M
    Leuk Lymphoma; 2002 Nov; 43(11):2241-3. PubMed ID: 12533057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical usefulness of tumor markers associated with pancreatic cancer].
    Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
    Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of urinary free fucose by fluorescence labeling and high-performance liquid chromatography.
    Suzuki J; Kondo A; Kato I; Hase S; Ikenaka T
    Clin Chem; 1992 May; 38(5):752-5. PubMed ID: 1582029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary free L-fucose (UFC) and urinary sulfated bile acids (U-SBA)].
    Mashige F
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():774-8. PubMed ID: 16149638
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2016 Mar; 16(4):537-43. PubMed ID: 27002756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the spectra of L-fucose].
    Liu H; Deng X; Fang W
    Guang Pu Xue Yu Guang Pu Fen Xi; 1998 Oct; 18(5):516-8. PubMed ID: 15825357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
    Tu Z; Xu S; Wu M
    Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer].
    Matsuda M; Shimizu Y; Chikamatsu E; Takayanagi K; Ishigure H; Murakami S; Odani K
    Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):716-21. PubMed ID: 1886576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of L-fucose assay as a tumor marker].
    Sakai T; Yamamoto K; Hino F; Kato I
    Nihon Rinsho; 1990 Feb; 48 Suppl():1025-7. PubMed ID: 2355500
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum and urinary fucose concentrations in hepatitis B-related cirrhosis and acute liver diseases.
    Sathish Kumar N; Eapen CE; Jeyamani R; Balasubramanian KA
    Clin Chim Acta; 2004 Apr; 342(1-2):233-5. PubMed ID: 15026286
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
    Kuhlmann KF; van Till JW; Boermeester MA; de Reuver PR; Tzvetanova ID; Offerhaus GJ; Ten Kate FJ; Busch OR; van Gulik TM; Gouma DJ; Crawford HC
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):886-91. PubMed ID: 17507610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary free fucose (UFC) and urinary sulfated bile acids (USBA)].
    Maekawa M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():814-7. PubMed ID: 20960878
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
    Anzai K; Kurihara M; Izumi T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity.
    Lwaleed BA; Francis JL; Chisholm M
    J Hematother Stem Cell Res; 1999 Dec; 8(6):659-68. PubMed ID: 10645774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.